BOLT vs MTD · rev $7.7M vs P/E 27, rev $3.87B
Bolt Biotherapeutics (BOLT) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
BOLT currently screens at market cap $11.3M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the BOLT and MTD stock pages for the full models.
Not investment advice.